29 October 2024
Oncology
Although often talked about generally, ‘cancer’ describes a diverse range of diseases (over 200 different types of cancer exist).i Each type of cancer is typically characterised by the presence of abnormal cells that divide in an uncontrollable wa...
16 October 2024
Home
Working with leading clinical centres across the U.K. & Ireland, Ipsen’s research focuses on oncology, neuroscience and rare diseases, investigating new compounds and increasing understanding of our licensed medicines....
-
25 June 2026
U.K. MHRA grants marketing authorisation for Ipsen’s Bylvay® (odevixibat) for cholestatic pruritus in Alagille syndrome, a rare liver disease
LONDON, U.K., 25 JUNE 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted Bylvay® (odevixibat) a new indication for the ...